NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 248 filers reported holding NEKTAR THERAPEUTICS in Q4 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $7,000 | -22.2% | 429 | +14.7% | 0.00% | 0.0% |
| Q2 2020 | $9,000 | -40.0% | 374 | -55.7% | 0.00% | -66.7% |
| Q1 2020 | $15,000 | 0.0% | 845 | +21.1% | 0.00% | -25.0% |
| Q4 2019 | $15,000 | -87.0% | 698 | -89.0% | 0.00% | -88.9% |
| Q3 2019 | $115,000 | +55.4% | 6,349 | +206.6% | 0.04% | +38.5% |
| Q2 2019 | $74,000 | +64.4% | 2,071 | +54.3% | 0.03% | +13.0% |
| Q1 2019 | $45,000 | +28.6% | 1,342 | +25.1% | 0.02% | +9.5% |
| Q4 2018 | $35,000 | +105.9% | 1,073 | +279.2% | 0.02% | +110.0% |
| Q3 2018 | $17,000 | -5.6% | 283 | -22.7% | 0.01% | 0.0% |
| Q2 2018 | $18,000 | – | 366 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 1,828,400 | $89,281,000 | 6.61% |
| Cormorant Asset Management, LP | 1,500,000 | $73,245,000 | 5.42% |
| Camber Capital Management LP | 2,000,000 | $97,660,000 | 3.76% |
| Rhenman & Partners Asset Management AB | 617,652 | $30,160,000 | 3.09% |
| BRIDGER MANAGEMENT, LLC | 1,134,414 | $55,393,000 | 3.00% |
| First Light Asset Management, LLC | 374,251 | $18,275,000 | 2.84% |
| Gs Investments, Inc. | 54,000 | $2,636,820,000 | 1.97% |
| SABBY MANAGEMENT, LLC | 241,922 | $11,813,000 | 1.82% |
| QUANTRES ASSET MANAGEMENT Ltd | 50,000 | $2,441,000 | 1.41% |
| Tibra Equities Europe Ltd | 173,183 | $8,457,000 | 1.27% |